Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma.
Forero A, Weiden PL, Vose JM, Knox SJ, LoBuglio AF, Hankins J, Goris ML, Picozzi VJ, Axworthy DB, Breitz HB, Sims RB, Ghalie RG, Shen S, Meredith RF.
Forero A, et al.
Blood. 2004 Jul 1;104(1):227-36. doi: 10.1182/blood-2003-09-3284. Epub 2004 Mar 2.
Blood. 2004.
PMID: 14996706
Free article.
Clinical Trial.